Orthocell Limited announced the first purchase orders of CelGroTM medical devices Striate+TM (for dental bone and tissue regeneration) and RemplirTM (for peripheral nerve repair) from partners BioHorizons and DVT respectively. First orders of Remplir, follow the appointment of DVT as the exclusive distributor of Remplir for peripheral nerve repair across Australia and New Zealand. DVT is committed to providing healthcare professionals with access to innovative, high-quality medical devices and solutions from around the world.

All products distributed by DVT are compliant with quality and regulatory requirements, with in-servicing, education and ongoing clinical and technical support provided as part of the trusted partnership between DVT and healthcare professionals. With high quality distribution partners, who have established relationships with surgeons and a successful track record in driving the market entry of high-quality products, Orthocell is well positioned to gain rapid product uptake and commercial traction in the US and Australia and expand into other global healthcare markets.